SCOTTSDALE, Ariz.—Although dorsal root ganglion stimulation (DRGS) therapy is a rapidly emerging modality to treat chronic pain, two common complications are lead migration and fracture.
Troubleshooting the challenges of DRGS therapy was highlighted in a case report at the American Academy of Pain Medicine 2022 Annual Meeting.
In October 2018, a 55-year-old white woman was implanted with a DRGS device for complex regional pain syndrome (CRPS) at the Cleveland Clinic Foundation in